Immuneering has reported 94% overall survival (OS) at six months in first-line pancreatic cancer, emboldening the biotech to ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

New trial data reveals atebimetinib combined with gemcitabine/nab-paclitaxel significantly improves survival rates in ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel ...

Urgent pancreatic cancer tests will be offered on the NHS for those who are most at risk. GPs taking part in the NHS pilot ...

After months of doctors' appointments, Kanisha Collins was told she has inoperable cancer; “I felt discriminated against ...

Revolution Medicines is advancing a groundbreaking pan-RAS inhibitor pipeline, targeting historically undruggable mutations ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and ...

A new blood test designed to detect early signs of pancreatic cancer is being trialled in the UK. The genomic test analyses ...

As an oncology chaplain with Banner Health, Peterson provides spiritual and emotional support for patients on a weekly basis. ABC15's Jordan Bontke talked with Peterson about her cancer journey and ...